Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 76 Leukemia, Myeloid, Acute 70 Prostatic Neoplasms 67 Neoplasm Metastasis 56 Carcinoma, Non-Small-Cell Lung 56 Breast Neoplasms 45 Multiple Myeloma 44 Colorectal Neoplasms 40 Pancreatic Neoplasms 36 Myelodysplastic Syndromes 35 Carcinoma, Renal Cell 33 Ovarian Neoplasms 31 Leukemia, Lymphocytic, Chronic, B-Cell 30 Melanoma 29 Precursor Cell Lymphoblastic Leukemia-Lymphoma 27 Glioblastoma 27 Triple Negative Breast Neoplasms 26 Lymphoma, Large B-Cell, Diffuse 26 Urinary Bladder Neoplasms 24 Lymphoma 23 Burkitt Lymphoma 22 Squamous Cell Carcinoma of Head and Neck 21 Glioma 20 Fallopian Tube Neoplasms 20 Carcinoma, Hepatocellular 18 Mouth Neoplasms 17 Leukemia, Biphenotypic, Acute 17 Brain Neoplasms 17 Sarcoma 16 Oropharyngeal Neoplasms 16

Interventions

Paclitaxel 24 Hyperthermic Intraperitoneal Chemotherapy 24 Cisplatin 22 Oxaliplatin 17 Carboplatin 17 Fluorouracil 13 Cytoreduction Surgical Procedures 13 Bevacizumab 10 Mitomycin 9 Leucovorin 8 Doxorubicin 8 Docetaxel 6 Gemcitabine 5 130-nm albumin-bound paclitaxel 5 Surgical Procedures, Operative 4 Blood Specimen Collection 4 Albumin-Bound Paclitaxel 4 sodium thiosulfate 3 liposomal doxorubicin 3 catumaxomab 3 Taxes 3 Neoadjuvant Therapy 3 Drug Therapy 3 tremelimumab 2 relacorilant 2 pembrolizumab 2 olaparib 2 nintedanib 2 epothilone B 2 Topotecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Peritoneal Neoplasms × Specimen Handling × Clear all

NCT07001748 2026-05-15

STOPGAP II

Eastern Cooperative Oncology Group

Phase 2/3 Recruiting

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡